Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

TNGX Q3 2020 Earnings — Tango Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TNGXTango Therapeutics, Inc.

$2B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$11M

Gross Profit

-$24M215.2% margin

Operating Income

-$27M237.6% margin

Net Income

-$27M238.0% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

-322.4%

Cash Flow

Operating Cash Flow

$111M

Free Cash Flow

$111M

Stock-Based Comp.

$418,000

Balance Sheet

Total Assets

$168M

Total Liabilities

$6M

Stockholders' Equity

$162M

Cash & Equivalents

$2M

← FY 2020 All Quarters Q4 2020 →